You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Adam covers proteomics and life science mass spectrometry for GenomeWeb.
Researchers at the Francis Crick Institute have used Sciex's Scanning Swath method to run 30-second mass spec experiments measuring thousands of proteins.
The immune profiling company is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application.
Several researchers have been collaborating with single-cell handling firm Cellenion to develop new tools that could expand access to single-cell proteomics.
New mass spec offerings indicate the field is making progress in plasma proteome profiling, though some researchers remain skeptical of the projected gains.
Led by Stanford researcher Michael Snyder, the project will use microsampling to collect information including proteomic, metabolomic, and antibody data.
Investor appetite for proteomics is growing, driven in part by improvements in mass spec but more significantly by new tech from early-stage firms soon to go public.
The TMT automation methods, developed separately by Calico and PreOmics, could help drive uptake of isobaric labeling for large cohort studies.
The company, whose targeted proteomic technology was featured in a pair of publications this week, is looking to raise around $30 million this year.
The company, which recently raised $6 million in seed funding, is using single-cell proteomic analysis to identify markers of response in cancer immunotherapy.
The aim is to improve the accuracy of the protein measurements commonly reported as the output of proteomic experiments and uncover obscured biological signals.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.